Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery

References

• Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359:492-507; PMID:18669428; http://dx.doi.org/10.1056/NEJMra0708126
   PubMed Web of Science ®Google Scholar
• Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010; 17:98-110; PMID:20129251; http://dx.doi.org/10.1016/j.ccr.2009.12.020
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 2014; 344:1396-401; PMID:24925914; http://dx.doi.org/10.1126/science.1254257
   PubMed Web of Science ®Google Scholar
• Rahbar A, Orrego A, Peredo I, Dzabic M, Wolmer-Solberg N, Straat K, Stragliotto G, Soderberg-Naucler C. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 2013; 57:36-42; PMID:23391370; http://dx.doi.org/10.1016/j.jcv.2012.12.018
   PubMed Web of Science ®Google Scholar
• Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347-50; PMID:12067971
   PubMed Web of Science ®Google Scholar
• Ranganathan P, Clark PA, Kuo JS, Salamat MS, Kalejta RF. Significant association of multiple human cytomegalovirus genomic Loci with glioblastoma multiforme samples. J Virol 2012; 86:854-64; PMID:22090104; http://dx.doi.org/10.1128/JVI.06097-11
   PubMed Web of Science ®Google Scholar
• Bhattacharjee B, Renzette N, Kowalik TF. Genetic analysis of cytomegalovirus in malignant gliomas. J Virol 2012; 86:6815-24; PMID:22496213; http://dx.doi.org/10.1128/JVI.00015-12
   PubMed Web of Science ®Google Scholar
• Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008; 10:10-8; PMID:17951512; http://dx.doi.org/10.1215/15228517-2007-035
   PubMed Web of Science ®Google Scholar
• Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91:119-26; PMID:9335340; http://dx.doi.org/10.1016/S0092-8674(01)80014-3
   PubMed Web of Science ®Google Scholar
• Sinclair J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J Clin Virol 2008; 41:180-5; PMID:18164651; http://dx.doi.org/10.1016/j.jcv.2007.11.014
   PubMed Web of Science ®Google Scholar
• Cheung TW, Teich SA. Cytomegalovirus infection in patients with HIV infection. Mt Sinai J Med 1999; 66:113-24; PMID:10100416
   PubMed Web of Science ®Google Scholar
• Peggs KS, Mackinnon S. Cytomegalovirus: the role of CMV post-haematopoietic stem cell transplantation. Int J Biochem Cell Biol 2004; 36:695-701; PMID:15072052; http://dx.doi.org/10.1016/j.biocel.2003.08.008
   PubMed Web of Science ®Google Scholar
• Rahbar A PI, Wolmer Solberg N, Taher C, Dzabic M, Xu X, Skarman P, Fornara O, Tammik C, Yaiw K, Wilhelmi V et al. Discordant humoral and cellular immune responses to cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. Oncoimmunology 2015; 4(2):e982391
   Web of Science ®Google Scholar
• Vallejo AN. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005; 205:158-69; PMID:15882352; http://dx.doi.org/10.1111/j.0105-2896.2005.00256.x
   PubMed Web of Science ®Google Scholar
• Strioga M, Pasukoniene V, Characiejus D. CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 2011; 134:17-32; PMID:21711350; http://dx.doi.org/10.1111/j.1365-2567.2011.03470.x
   PubMed Web of Science ®Google Scholar
• Koller L, Richter B, Goliasch G, Blum S, Korpak M, Zorn G, Brekalo M, Maurer G, Wojta J, Pacher R et al. CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure. Atherosclerosis 2013; 230:414-6; PMID:24075776; http://dx.doi.org/10.1016/j.atherosclerosis.2013.08.008
   PubMed Web of Science ®Google Scholar
• Betjes MG, Meijers RW, de Wit LE, Litjens NH. A killer on the road: circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol 2012; 25:183-91; PMID:22135034; http://dx.doi.org/10.5301/jn.5000057
   PubMed Web of Science ®Google Scholar
• Fasth AE, Snir O, Johansson AA, Nordmark B, Rahbar A, Af Klint E, Bjorkstrom NK, Ulfgren AK, van Vollenhoven RF, Malmstrom V et al. Skewed distribution of proinflammatory CD4+CD28null T cells in rheumatoid arthritis. Arthritis Res Ther 2007; 9:R87; PMID:17825098; http://dx.doi.org/10.1186/ar2286
   PubMedGoogle Scholar
• Pandya JM, Fasth AE, Zong M, Arnardottir S, Dani L, Lindroos E, Malmstrom V, Lundberg IE. Expanded T cell receptor Vbeta-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum 2010; 62:3457-66; PMID:20662057; http://dx.doi.org/10.1002/art.27665
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T. Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis 2007; 13:837-46; PMID:17285595; http://dx.doi.org/10.1002/ibd.20113
   PubMed Web of Science ®Google Scholar
• Dumitriu IE, Araguas ET, Baboonian C, Kaski JC. CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res 2009; 81:11-9; PMID:18818214; http://dx.doi.org/10.1093/cvr/cvn248
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Remmerswaal EB, Heemskerk MH, ten Berge IJ, van Lier RA. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 2006; 108:3121-7; PMID:16840731; http://dx.doi.org/10.1182/blood-2006-03-006809
   PubMed Web of Science ®Google Scholar
• van Leeuwen EM, Remmerswaal EB, Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173:1834-41; PMID:15265915; http://dx.doi.org/10.4049/jimmunol.173.3.1834
   PubMed Web of Science ®Google Scholar
• Di Girolamo W, Coronato S, Portiansky E, Laguens G. Profile of immune cells in lymph nodes draining human malignant tumors. Medicina (B Aires) 2008; 68:423-7; PMID:19147422
   PubMed Web of Science ®Google Scholar
• Wang EC, Borysiewicz LK. The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections. Scand J Infect Dis Suppl 1995; 99:69-77; PMID:8668946
   PubMedGoogle Scholar
• Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 2010; 87:107-16; PMID:19880576; http://dx.doi.org/10.1189/jlb.0809566.
   PubMed Web of Science ®Google Scholar
• Nielsen CM, White MJ, Goodier MR, Riley EM. Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease. Front Immunol 2013; 4:422; PMID:24367364; http://dx.doi.org/10.3389/fimmu.2013.00422
   PubMed Web of Science ®Google Scholar
• Marquez-Medina D, Salla-Fortuny J, Salud-Salvia A. Role of gamma-delta T-cells in cancer: another opening door to immunotherapy. Clin Transl Oncol 2012; 14:891-5; PMID:23054752; http://dx.doi.org/10.1007/s12094-012-0935-7
   PubMed Web of Science ®Google Scholar
• Bryant NL, Suarez-Cuervo C, Gillespie GY, Markert JM, Nabors LB, Meleth S, Lopez RD, Lamb LS Jr. Characterization and immunotherapeutic potential of gammadelta T-cells in patients with glioblastoma. Neuro Oncol 2009; 11:357-67; PMID:19211933; http://dx.doi.org/10.1215/15228517-2008-111
   PubMed Web of Science ®Google Scholar
• Bryant NL, Gillespie GY, Lopez RD, Markert JM, Cloud GA, Langford CP, Arnouk H, Su Y, Haines HL, Suarez-Cuervo C et al. Preclinical evaluation of ex vivo expanded/activated gammadelta T cells for immunotherapy of glioblastoma multiforme. J Neurooncol 2011; 101:179-88; PMID:20532954; http://dx.doi.org/10.1007/s11060-010-0245-2
   PubMed Web of Science ®Google Scholar
• Dechanet J, Merville P, Lim A, Retiere C, Pitard V, Lafarge X, Michelson S, Meric C, Hallet MM, Kourilsky P et al. Implication of gammadelta T cells in the human immune response to cytomegalovirus. J Clin Invest 1999; 103:1437-49; PMID:10330426; http://dx.doi.org/10.1172/JCI5409
   PubMed Web of Science ®Google Scholar
• Morford LA, Dix AR, Brooks WH, Roszman TL. Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors. J Neurosurg 1999; 91:935-46; PMID:10584838; http://dx.doi.org/10.3171/jns.1999.91.6.0935
   PubMed Web of Science ®Google Scholar
• Dix AR, Brooks WH, Roszman TL, Morford LA. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol 1999; 100:216-32; PMID:10695732; http://dx.doi.org/10.1016/S0165-5728(99)00203-9
   PubMed Web of Science ®Google Scholar
• Bhondeley MK, Mehra RD, Mehra NK, Mohapatra AK, Tandon PN, Roy S, Bijlani V. Imbalances in T cell subpopulations in human gliomas. J Neurosurg 1988; 68:589-93; PMID:3258364; http://dx.doi.org/10.3171/jns.1988.68.4.0589
   PubMed Web of Science ®Google Scholar
• Spencer JV, Lockridge KM, Barry PA, Lin G, Tsang M, Penfold ME, Schall TJ. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 2002; 76:1285-92; PMID:11773404; http://dx.doi.org/10.1128/JVI.76.3.1285-1292.2002
   PubMed Web of Science ®Google Scholar
• van den Berg AP, Klompmaker IJ, Haagsma EB, Peeters PM, Meerman L, Verwer R, The TH, Slooff MJ. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. Clin Transplant 1996; 10:224-31; PMID:8664524
   PubMed Web of Science ®Google Scholar
• Hengel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol 1998; 6:190-7; PMID:9614343; http://dx.doi.org/10.1016/S0966-842X(98)01255-4
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Saccani S, Izotova LS, Mirochnitchenko OV, Pestka S. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 2000; 97:1695-700; PMID:10677520; http://dx.doi.org/10.1073/pnas.97.4.1695
   PubMed Web of Science ®Google Scholar
• Dziurzynski K, Wei J, Qiao W, Hatiboglu MA, Kong LY, Wu A, Wang Y, Cahill D, Levine N, Prabhu S et al. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin Cancer Res 2011; 17:4642-9; PMID:21490182; http://dx.doi.org/10.1158/1078-0432.CCR-11-0414
   PubMed Web of Science ®Google Scholar
• Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G et al. Comparison of glioma-associated antigen peptide-loaded vs. autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother 2013; 36:152-7; PMID:23377664; http://dx.doi.org/10.1097/CJI.0b013e3182811ae4
   PubMed Web of Science ®Google Scholar
• Hegde M, Bielamowicz KJ, Ahmed N. Novel approaches and mechanisms of immunotherapy for glioblastoma. Discov Med 2014; 17:145-54; PMID:24641957
   PubMed Web of Science ®Google Scholar
• Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J, Liu R, Johnson LA, Weinhold K, Archer GE et al. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells. Clin Cancer Res 2014; 20:2684-94; PMID:24658154; http://dx.doi.org/10.1158/1078-0432.CCR-13-3268
   PubMed Web of Science ®Google Scholar
• Effros RB. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev Comp Immunol 1997; 21:471-8; PMID:9463780; http://dx.doi.org/10.1016/S0145-305X(97)00027-X
   PubMed Web of Science ®Google Scholar
• Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(−) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168:5893-9; PMID:12023394; http://dx.doi.org/10.4049/jimmunol.168.11.5893
   PubMed Web of Science ®Google Scholar
• Godlove J, Chiu WK, Weng NP. Gene expression and generation of CD28-CD8 T cells mediated by interleukin 15. Exp Gerontol 2007; 42:412-5; PMID:17204390; http://dx.doi.org/10.1016/j.exger.2006.11.015
   PubMed Web of Science ®Google Scholar
• Chou JP, Effros RB. T cell replicative senescence in human aging. Curr Pharm Des 2013; 19:1680-98; PMID:23061726
   PubMed Web of Science ®Google Scholar
• Pourgheysari B, Khan N, Best D, Bruton R, Nayak L, Moss PA. The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire. J Virol 2007; 81:7759-65; PMID:17409149; http://dx.doi.org/10.1128/JVI.01262-06
   PubMed Web of Science ®Google Scholar
• Moro-Garcia MA, Alonso-Arias R, Lopez-Larrea C. When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes. Front Immunol 2013; 4:107; PMID:23675374; http://dx.doi.org/10.3389/fimmu.2013.00107
   PubMed Web of Science ®Google Scholar
• Vasudev A, Tan Tze Ying C, Ayyadhury S, Joo Puan K, Kumar Andiappan A, Shwe Zin Nyunt M, Binte Shadan N, Mustafa S, Low I, Rotzschke O et al. gamma/delta T cell subsets in human aging using the classical α/β T cell model. J Leukoc Biol 2014; 96(4):647–55; PMID:25001861; http://dx.doi.org/10.1189/jlb.5A1213-650RR
   PubMed Web of Science ®Google Scholar
• Sinclair JH, Reeves MB. Human cytomegalovirus manipulation of latently infected cells. Viruses 2013; 5:2803-24; PMID:24284875; http://dx.doi.org/10.3390/v5112803
   PubMed Web of Science ®Google Scholar
• Tsukishiro T, Donnenberg AD, Whiteside TL. Rapid turnover of the CD8(+)CD28(−) T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol Immunother 2003; 52:599-607; PMID:12827303; http://dx.doi.org/10.1007/s00262-003-0395-6
   PubMed Web of Science ®Google Scholar
• Fedio WM, Wendakoon CN, Zapata R, Carrillo C, Browning P. Comparison of Petrifilm Staph Express Count System with the bacteriological analytical manual direct-plating method for enumeration of Staphylococcus aureus in artificially contaminated hard cheese. J AOAC Int 2008; 91:1138-41; PMID:18980130
   PubMed Web of Science ®Google Scholar